ARCHIVES

Conversation With The Cancer Letter: Seffrin To Retire After Restructuring ACS

This article is from The Cancer Letter archive.

Vol. 40 No. 04 | January 24, 2014

Download PDF Visit The Full Archive

Related Articles

AACR Meeting: Celebrex Studies Show Benign Polyp Reduction, Point To Challenges In Biomarker Validation.

April 14, 2006

Court Agreement Clears The Way For Human Gene Transplant Study

May 26, 1989

NKTR-102 Shows 29 Percent Response in Phase II Study

September 30, 2011

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

May 31, 2013

Center Studies Prevention For Endometrial Cancer

February 25, 2005

NSABP Operations Office Moves Across Town To Allegheny

December 13, 1996